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Influence of ovarian hormones on the central oxytocin induced
stimulation of luteinizing hormone (LH) in ovariectomized rats
Director: Craig A. Johnston, Ph.D
Central oxytocin (oxy) can stimulate LH secretion in
cycling female proestrous rats, but not in metestrous or
diestrous rats. Gonadal steroids play a critical role in
regulating the influence of oxy on LH secretion. To examine
the influence of estradiol (E2) and/or progesterone (P4)
directly, the effects of dose and duration of E2 and P4
exposure on the oxy stimulation of LH release was examined in
ovariectomized (OVX) rats. For chronic exposure, subcutaneous
time-release pellets containing vehicle, E2, P4 or both
hormones were implanted in OVX rats. For short term exposure,
various doses of P4 were administered, s.c. , at 900 hr in OVX,
E2-primed or OVX animals. Central injections of oxy were given
through stereotaxically-placed, intracerebroventricular (icv)
cannulae. Plasma samples were obtained via jugular cannulae
from the unanesthetized, freely moving rats at 10 min before
(Pre) and at 5, 15, 30 and 60 min following icv injection.
Basal LH levels were highest in OVX animals, and responded to
icv oxy with a modest decrease at 30 and 60 min. E2 or P4
replacement lowered basal LH levels, and the combination of E2
and P4 lowered basal LH even more. The results of oxy
injection in E2-treated animals were variable, but in most
cases caused a small increase in plasma LH. In animals treated
with P4, alone, oxy injection did not alter plasma LH. In E2primed animals, the acute injection of P4 caused a bell-shaped
dose-response curve with low doses allowing some stimulation
of LH release in response to central oxy injection, 2.5 mg P4
causing a dramatic synergism with E2 on the LH response, and
higher doses causing a diminished response. The results prove
the stimulatory effect of centrally administered oxy can be
seen in a pharmacological model of the proestrous female rat.
In the absence of E2 or P4, oxy exerts an inhibitory influence
on plasma LH. The level of stimulation by oxy on plasma LH was
critically dependent on the optimal dose and time of P4 as
well as E2 priming.
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CHAPTER 1
INTRODUCTION

I. Neurotransmitt«rs/Neuropeptides and Luteinizing Hormone
Secretion

The primary neuroendocrine factor responsible for
triggering the preovulatory surge of luteinizing hormone (LH)
in mammals is the hypothalamic factor,

luteinizing hormone

releasing hormone (LHRH), which directly stimulates LH release
from gonadotrophs located in the adenohypophysis (1-3). It is
also

accepted

that

many

other

factors

modulate

this

regulation. The important role which LH exerts in stimulating
ovulation is universally recognized (3).
Several

neuropeptide

and

neurotransmitter

substances

contained within the central nervous system have been reported
to play a significant physiological role in the regulation of
LHRH

and

LH

release.

neurotransmitter
stimulate

which

Norepinephrine
has

been

(NE)

shown

is a monoamine
to

consistently

LH release in a dose-related fashion in estrogen

and progesterone treated ovariectomized rats or in intact,
cycling

female

proestrous

rats

(4-7).

Other

numerous

neuropeptides may play a role in the neuroendocrine regulation
of LH secretion which depends upon the presence of gonadal
steroids.

neuropeptide

Y

(NPY)

and

the

related
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pancreatic

polypeptide

stimulate

LH

secretion,

but

the

response depends upon the presence of gonadal steroids (8-10).
Steele

et

al

(11)

demonstrated

that

angiotensin

II

can

stimulate LH secretion by working at central sites, glutamate
has

also

been

found

stimulating hormone

to

stimulate

LH,

(FSH), secretion

but

not

follicle

in estrogen-treated,

ovariectomized immature rats (12). Endogenous opioid peptide
neurons are recognized as a hypothalamic network which exerts
a powerful inhibitory influence on gonadotropin secretion. It
is obvious that each of the opiate receptor subtypes in the
hypothalamus can suppress LH release when activated by an
appropriate

opiate

inhibitory

factor

receptor
on

LH

agonist

secretion

is

(13-14).
GABA

Another

(15).

This

inhibitory system inhibits LH secretion via GABA receptors and
it

operates

without

mediation

Corticotropin-releasing factor
secretion,

by
(CRF)

the

NE

system

(15).

can also suppress LH

and this action is through its stimulating the

release of hypothalamic opioid peptides (16).

II. Central role of oxytocin in LH secretion

Hormonal

functions

for

oxytocin

on

the

female

reproductive system are well established. During parturition,
oxytocin regulates the contraction of the uterine wall and,
during lactation,

oxytocin triggers milk-ejection from the

mammary gland (17). Several studies on the maternal behavior
(17-18) and female sexual behavior (19-21) of the rat indicate
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that oxytocin also plays a role in these behaviors in the
central nervous system. Other studies indicate a possible role
for oxytocin in the neuroendocrine regulation of anterior
pituitary hormone secretion.

Synthetic oxytocin stimulates

prolactin secretion from the anterior pituitary both in vivo
and in vitro (21-22).

Oxytocin can influence the secretion of

ACTH from the pituitary gland (23-26). Oxytocin has also been
reported to stimulate gonadotropin-releasing activity in vivo.
For example, oxytocin induced an increase in number and size
of gonadotrophs in rats and dogs, increased testicular weight,
enhanced urinary excretion of 17-keto steroids

in rabbits

(27) , and increased urinary gonadotropin excretion (28-29).
Recent reports indicate a physiological role for oxytocin in
the neuroendocrine regulation of LH secretion (30-35). The
first evidence that oxytocin might stimulate gonadotropin
secretion was proposed in 1988 (30). It was later demonstrated
that oxytocin can stimulate gonadotropin secretion from rat
anterior

pituitary

cells

in

static

culture

(3 6).

findings suggest that the observed accelerated

These

follicular

maturation and ovulation in mice given oxytocin might have
been

a

result

gonadotropins,
elucidated

of

oxytocin-induced

although

(37).

the

Oxytocin

is

release

of

endocrine

events

released

directly

pituitary
were

not

into

the

hypophyseal portal blood system and could, therefore, affect
LH secretion directly from the anterior pituitary (35-36).
Furthermore, oxytocin neurons send projections which terminate
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in many areas of the brain containing cell bodies or terminals
of LHRH neurons or other LHRH secretagogues (38-42). However,
there is a controversy concerning how oxytocin influences LH
secretion. Some reports have indicated that the actions of
oxytocin on LH release are primarily inhibitory in nature and
are mediated through actions on central LHRH neurons

(36) .

other reports suggest the action of oxytocin on LH release is
minor at best

(43) . On the other hand,

supporting a physiologically relevant

there is evidence

stimulatory influence

of oxytocin on the secretion of LH from the anterior pituitary
mediated primarily at a central

site

(30).

result in the preovulatory release of LH

These actions

(32) . The latter

studies utilized a physiological animal model of the female
cycling rat on proestrus (when plasma levels of estradiol are
physiologically high). The earlier studies showing inhibitory
or

little action of oxytocin on LH release used male or

ovariectomized female rats

(both of which have low plasma

estradiol levels). The results indicate that in order for
oxytocin

to

stimulate

LH

secretion,

physiologically

high

levels of estradiol must be present (32).
Much evidence suggests estradiol plays a predominant
role in the excitation of preovulatory LH release.
variety of experiments,
required for the

From a

it is apparent that estradiol

is

stimulation of LH release in ovariectomized

rats (6, 8, 9, 11). Estrogens and progesterone have also been
shown to increase the number of oxytocin receptors in some
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areas of the brain (44-45). Additionally, gonadal steroids, in
particular estradiol, are known to have multiple effects upon
central oxytocin neurons. Administration of estradiol enhances
the electrical activity of magnocellular oxytocin neurons (4445), stimulates oxytocin secretion into the pituitary portal
circulation (46) , and releases oxytocin associated neurophysin
into the peripheral circulation (47-49). Finally, receptors
for estradiol are found on central oxytocin neurons (3) but
not on central LHRH neurons.

1)

Distribution

of

oxytocinergic

neurons

in

the

central

nervous system
Oxytocin, synthesized in the hypothalamus and released
from

the

posterior

pituitary,

has

been

associated

with

immunoreactive neurons not only in the classical magnocellular
groups (the paraventricular and supraoptic nuclei), but also
in the anterior commissural nucleus, medial preoptic area,
periventricular
(internuclear)
circularis,

zona

stratum,
group,

intersupraopticoparaventricular
perifornical

nucleus,

nucleus

incerta and the ventral nucleus of ansa

lenticularis (50-51). Besides the well-known projections to
the posterior pituitary, oxytocinergic neurons project to the
external zone of the median eminence (52), to the brain stem
and spinal cord (53), and to olfactory and limbic targets (5456) .
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2) Estradiol interactions with central oxytocin neurons
Oxytocin's

involvement

with

reproductive

functions

centering on parturition and maternal and receptive behavior
may be, in part, influenced by estrogen.

Concentrations of

oxytocin in the pituitary have been found to fluctuate with
the estrous cycle (57), Oxytocin levels in the portal blood
increase on the afternoon of proestrus, correlating with the
onset of sexual receptivity as well as the preovulatory LH
surge (47). Estrogen treatment can increase oxytocin release
from the pituitary (58). Correspondingly, oxytocin content of
anterior

commissural

neurons

decreases

with

estrogen

treatment, perhaps associated with increased oxytocin release
from these neurons (59). Some oxytocin immunoreactive neurons
in portions of the paraventricular nucleus and a few cells in
the anterior commissural nucleus accumulate estrogen in the
cell nucleus (60-62). These immunocytochemical studies show
both

increased

oxytocin

distribution of

oxytocin

estrogen

treatment

in

immunoreactivity
immunoreactive

the

anterior

and

neurons

commissural

increased
following
nucleus,

anterior hypothalamic area, septohypothalaroic nucleus, medial
preoptic area, perifornical nucleus, and zona incerta (50-51,
61) .
Recent experiments have utilized in situ hybridization
to study possible estrogen influences on oxytocin messenger
RNA

levels.

anterior

These

studies

hypothalamic

concentrated

levels

because

on
of

preoptic
the
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involvement
release

of

oxytocin

in

LHRH

function

influencing

LH

(30) and because of demonstrated preoptic sites of

action of oxytocin in female sexual behaviors (63). Analysis
of oxytocin-expressing neurons included the numbers of cells
labeled with in situ hybridization procedures as well as the
numbers

of

grains

per

labeled

cell

because

these

two

parameters can change independently.
The possibility of direct involvement of estradiol with
oxytocin or vasopressin-producing neurons was suggested by
observations of tritiated estradiol binding in the cell nuclei
of neurophysin-immunoreactive neurons (61-62). Using northern
blot and dot blot analysis» Van Toi et al (64) demonstrated a
significant

increase

in

oxytocin

mRNA

levels

during

the

estrous phase of the female rat's cycle to almost twice the
levels seen on
female

rat

diestrus. Oxytocin mRNA in the brain of the

is

increased

concomitant

with

puberty,

and

ovariectomy of adult females decreased oxytocin mRNA values
(65); both observations consistent with estrogen stimulation
of oxytocin. Significant elevations of oxytocin mRNA during
the

late stages of pregnancy also suggest

increased gene

transcription under the influence of ovarian hormones (66).
Radioimmunoassay of oxytocin in micropunches from the medial
preoptic

area

revealed

significantly

increased

levels

in

estrogen-progesterone-treated animals which were behaviorally
receptive
detectable

(59),

while

oxytocin

the

cell

number
bodies

of

immunocytochemically

actually

decreased.
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configuration

of

results

suggested

a

greater

expression per oxytocin-producing neuron.

amount

of

Jirikowski et al

(51) reported a stimulatory effect of short-term estradiol
treatment on the distribution of immunoreactive cell bodies.
Greater numbers of oxytocin immunoreactive neurons were seen
in the septohypothalamic nucleus, the lateral subcommissural
area, the medial preoptic area, the perifornical region, the
zona incerta, and the ansa lenticularis. Finally, a number of
experimental approaches in different species have suggested
strongly that estrogen treatment facilitates oxytocin release
(48,

58).

Under

these

circumstances,

where

release

is

increased by estrogen and immunoreactive content is either not
changed or is increased, elevated transcription and/or mRNA
stability is to be expected.
The mechanisms

of estrogen

effects

on

oxytocin mRNA

levels are unclear. The possibility of a direct effect of the
estrogen

receptor

on

transcription

is

indicated

by

the

presence of these partial estrogen-response-elements upstream
to the oxytocin transcription start site (67-69) . On the other
hand, significant numbers of supraoptic neurons with nuclear
estrogen receptors have not been identified (70). There may be
an analogy to control of the LHRH gene, where a long estrogen
treatment can lead to increased mRNA levels (71-72) and where
the stimulatory effects of estrogen can be interpreted as
consequent to the release of the neuroendocrine peptide (73).
Co-existence of oxytocin and of estrogen receptor in the same
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neurons raises questions regarding their possible functional
significance. Changes in the oxytocin levels in circulation
after estrogen treatment (58) and during the estrous cycle in
the PVN (74) and in the pituitary (57) have been reported.
Results

of

these

studies

suggest

that

physiological

fluctuation in ovarian steroid levels affect the release of
neurohypophyseal hormones. Although the intensity of oxytocin
immunostaining of perikarya and processes in several brain
sites vary after estrogen treatment,

it is impossible to

explain whether the increased immunostaining after estradiol
treatment is due to an increased synthesis of peptide or to an
inhibition of its secretion. Existence of estrogen receptor
protein

in

an

identical

population

of

neurons

does

not

represent complete proof that estrogen regulates the synthesis
of that peptide. However, recent studies using a hybridization
assay on the levels of rat hypothalamic oxytocin mRNA during
gestation,

lactation and the estrous cycle

(64,75-76)

have

shown that the expression of oxytocin gene was stimulated
concomitantly with an increase in serum estrogen levels during
the estrous

cycle and pregnancy

(77).

These observations

suggest that estrogens may be involved in regulating oxytocin
gene expression. Recent studies by Richard and Zingg (78) ,
demonstrate that beta-estradiol administration stimulates the
transcriptional activity of the human oxytocin gene promoter
by a direct estrogen receptor dependent mechanism. Anatomical
evidence that an estrogen-stimu1ated release of oxytocin from
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the posterior pituitary is mediated by a direct effect of
estrogen

on

magnocellular

hypothalamic

neurons

has

also

recently been published (79),

3) Gonadal hormones and LH secretion
Although a lot of evidence gathered over the years has
documented

the feedback action of gonadal steroids in the

hypothalamus and pituitary in the neuroendocrine regulation of
LHRH

and

LH secretion,

the

mechanisms

involved

in

these

actions have not yet been precisely delineated.
Several lines of evidence indicate that estradiol is the
critical stimulus for the preovulatory surge of gonadotropins.
In intact cycling female rats, the serum levels of LH are

low

from early on the morning of estrus, shortly after ovulation,
through metestrus, diestrus, and midday on proestrus

(80) .

Though most studies have reported basal unchanging levels of
LH over this time (80-84), one study reported a significant
diurnal variation throughout the cycle (85). This circadian
pattern from estrus through diestrus consisted of a small
elevation of LH each day at the midpoint of the light period,
and the lowest levels by midnight of each day. On the late
afternoon of proestrus (actual time of initiation depending on
the

light

cycle)

the

circulating

levels

of

LH

begin

to

increase rapidly and ultimately reach peak levels by 1700-1900
hr on that same evening.

This rapid surge of LH induces

follicular rupture and ovulation. Thereafter, the blood levels
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of LH begin to decline and reach basal levels by early on the
morning of estrus.
There is a voluminous literature indicating that ovarian
estradiol,

secreted on diestrus,

is a critical

positive-

feedback stimulus for the ovulation-inducing surge Of LH.
Several experimental approaches have attested to this fact.
Specifically, under either a 14:10 or 12:12 light-dark cycle,
with

noon

as

the

ovariectomized
estradiol

by

midpoint

rats will
presenting

of

the

respond
a

light

to

interval

a dose

proestrous-like

of
LH

(86) ,

exogenous
surge

the

following day with the same timing and duration as the intact
female rat on proestrus (86-88), However, the magnitude of
this induced surge differs from that of the spontaneous surge
on proestrus. That is, base-line values are not as low and
peak values are not as high as those obtained during the
endogenous

surge

stimulating

a

on

surge

proestrus.
of

LH

on

In

addition,

a

single

rather

day,

administration to ovariectomized animals results

than

estradiol
in an LH

surge of equivalent timing on each of at least the following
3 days. Thus, a daily neural event must be coupled with the
presence of estrogen to eventuate in a daily LH surge in the
ovariectomized

rat.

original proposal

This

confirms

Everett

and

Sawyer's

(89) of a 24 hr. periodicity in the LH

release apparatus. Other approaches have demonstrated that
ovarian estradiol secreted on diestrus is required to activate
the

LH

surge

response

on

proestrus.

Specifically,
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administration

of

estrogen

inhibitors

(90)

or

estradiol

antiserum (90-92) or ovariectomy (93) on diestrus bloc)cs the
proestrous surge of LH. On the other hand, administration of
these agents or removal of the ovaries early on proestrus is
ineffective in preventing this response later that same day.
These data, taken together, suggest that the rising titer of
estradiol secreted on diestrus represents a major stimulus for
the increased secretion of LH on proestrus. The tonic levels
of LH secreted on diestrus contribute to the stimulation of
estradiol secretion by the ovarian follicle which, in turn,
stimulates LH secretion (94).
The long-term ovariectomized rat responds to a brief
exposure (only 4 to 5 days) to estradiol with daily LH surges,
whereas

the

acutely

ovariectomized

rat

requires

chronic

exposure to estradiol to secrete daily LH surges (88). Also,
it has been shown that expression of the daily LH surge
mechanism is limited to proestrus by the heightened secretion
of

progesterone

on proestrus

(87).

Thus,

there

is

every

indication from the present data as well as previous reports
that

progesterone

secretion

of

the

contributes
surge

of

in
LH

a
on

positive

way

proestrus.

In

to

the

fact,

progesterone administered early on the morning of proestrus
will advance LH release by several hours
progesterone

administrated

to

(95).

ovariectomized,

Similarly,
estradiol-

benzoate-pretreated rats will induce an LH surge during the
afternoon of that same day (106) . In addition, progesterone
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will enhance the magnitude of the estrogen-induced LH surge
(96). The effect of estrogen to increase LHRH release may not
be exerted directly on LHRH-containing neurons since only 1 in
435 LHRH neurons reportedly have estrogen receptors (97) . The
effect of progesterone appears not to be mediated through the
ovary

since

studies

stimulates

in

the

gonadotropin

ovariectomized

rats

rat

have

secretion

primed

with

shown
in

estradiol

progesterone
bilaterally
(98-100).

The

stimulatory effect of progesterone does, however, require the
presence of estradiol, as evidenced by the lack of effect of
progesterone on gonadotropin secretion in ovariectomized rats
not

given

estrogen

replacement

(101-102).

The

critical

dependence of progesterone on estradiol for the induction of
progesterone

receptors

is

important

(103-104);

however,

estradiol may also exert other important priming effects, such
as setting the neural trigger for progesterone activation. On
the other hand,

the data also suggest that the proestrous

surge of LH may be terminated, in part, by the secretion of
progesterone.
Progesterone's

effect upon

gonadotropin

secretion

is

dependent not only upon time of administration but also upon
the dose of administration. Freeman et al (105) found that the
injection of progesterone to estradiol benzoate-treated, long
term ovariectomized rats resulted in an enhancement of the LH
surge on the first day,

and elimination of the surge on

following days (105). The role of endogenous progesterone to
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limit the expression of the gonadotropin surge to a single day
was further confirmed by the study of Smith et al (106), who
demonstrated that blockade of progesterone's effects on the
afternoon

of proestrus

with

either

progesterone

antibody

administration or the antiprogestin, RU486, caused a return of
pulsatile LH secretion on estrus.
In addition to direct effects at the anterior pituitary,
progesterone may regulate hypothalamic release and degradation
of LHRH as a mechanism in its positive feedback effect on
gonadotropin secretion; however, it appears unlikely that this
action of progesterone is exerted directly on LHRH-containing
neurons since progesterone receptors are not reported to be
present on hypothalamic LHRH neurons (107), It appears more
likely that progesterone's effect on LHRH is exerted through
neurotransmitter/neuropeptide-containing

neurons

in

the

hypothalamus which interact with LHRH neurons.
Numerous

studies

have demonstrated that

enhances the pituitary response to LHRH
progesterone
suppresses,

treatment

enhances,

while

progesterone

(108-113).
chronic

the pituitary response to LHRH.

Acute

treatment

The

cellular

mechanism involved in the acute progesterone enhancement of
LHRH response is unclear. One possible mechanism could be the
modulation of LHRH receptors.
Attardi

and

progesterone
suggesting

Happe
on
the

(110)

However,

failed

LHRH

receptor

site

of

to

a recent

study by

show

any

effect

in

the

pituitary,

number

progesterone

action
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independent of effects on the LHRH receptor. Krey and Kamel
(111)

recently

reported

that

progesterone

enhances

the

pituitary LH response to secretagogues which act separate from
the LHRH receptor.
Progesterone

can

modify

the

action

of

estradiol

by

decreasing nuclear estradiol receptor retention (114-115) . The
reduction

of

occupied

equivalent

to

causing

nuclear
a

fall

estradiol

in

receptors

serum estradiol

is

levels,

because estradiol *s action is exerted through its occupied
nuclear receptors.
These reports demonstrate the crucial role played by
progesterone in the regulation of gonadotropin secretion. The
regulatory role of progesterone on gonadotropin secretion
depends

on

the

time

and

dose

of

its

administration

in

relationship to the adequacy of estrogen priming.

All this information suggests to us that the effects of
estradiol and progesterone are partly exerted through other
neurotransmitter(s)/neuropeptide(s), and the central role of
those factors. Verification of this hypothesis requires more
research.

The review summarized here suggests that oxytocin

neurosecretion, itself, as well as its central influence on LH
secretion, is subject to modulation by gonadal steroids and
may represent a significant portion of this neuroendocrine
control.
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CHAPTER II
OBJECTIVES:

The

major

objectives

of

this

research

are

to

1)

demonstrate the important role of central oxytocin in the
regulation of LH secretion in the pharmacological model of the
proestrous LH surge,

2) to determine and characterize if that

stimulatory role is influenced by gonadal hormone levels in
vivo and 3) to study the interaction of different gonadal
hormones on the oxytoe in-induced stimulation of LH secretion.
Previous

experiments

in

our

laboratory

suggest

that

central oxytocin neurons may exert a physiologically important
stimulatory influence on the release of LHRH and LH occurring
just prior to ovulation on the afternoon of proestrus in the
cycling female rat (when estradiol levels are physiologically
high)(32). Another recent report showed that the in vitro LH
response

to

oxytocin at

the

anterior

pituitary

level

is

steroid-dependent(106). This research tested the hypothesis
that the central stimulatory role of oxytocin on LH secretion
is subject to modulation by the levels, concentration ratios
and time of exposure of gonadal hormones.
To

investigate

these

possibilities,

we

utilized

ovariectomized, estrogen, or both estrogen and progesteroneprimed female rats as an in vivo pharmacological model for the
proestrous female rat. The results were planned to further
16
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confirm the central effect of oxytocin on LH release and the
dependence of its action on plasma estradiol and progesterone
levels in a pharmacological model for the preovulatory surge.
The knowledge gained from this research might advance our
basic

understanding

physiological

of

the

significance

nature,

of

site,

oxytocin

in

mechanism

and

regulating

the

preovulatory surge of LH and the influence of gonadal hormones
on that neuroendocrine regulation.

It might also offer an

ideal experimental model for the study of the interaction
between

oxytocin

and

other

physiologically

relevant

secretagogues.
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CHAPTER III

MATERIALS AMD METHODS

1) Animals:
Young adult female, ovariectomized, Sprague Dawley rats
(200-300 g, BW) were housed in a temperature

(22±l*C)

and

light ( light on 700-1900 h) controlled room. Ovariectomies
were done at least 4 weeks prior to further experiments. The
rats were supplied food and water

ad libitum.

2)Surgery:
a. Third ventricular cannulae placement (icv):
Stainless-steel 23 gauge cannulae were stereotaxically
placed into the third cerebral ventricle of the ovariectomized
rats using the atlas of Kdnig and Klippel (107) as a guide
under tribromoethanol (1 ml/100 g B.W. of a 2.5% solution in
saline) anesthesia. Coordinates utilized for placement of the
icv

cannulae

were

lateral

0.0

mm

from

midline,

2.5

mm

posterior to bregma, and approximately -8.5 mm ventral to the
surface of the brain. Each cannula was secured with dental
cement and fine microscrews, and was provided with a screw-in
mandril to prevent its obstruction. Location of the cannulae
were confirmed by the flow of cerebrospinal fluid through the
cannulae after removal

of the mandril

and by a positive

18
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drinking response to the icv injection of 10 ng angiotensin II
(a positive drinking response started not more than one minute
after icv injection of angiotensin II with a total consumption
of water of greater than 3 ml within 30 minutes).
At

the

time

of

the

experiment,

the

mandril

of

the

cannulae were removed and injections were made using a 10
microliter Hamilton

(Hamilton Industries,

Two Rivers,

WI)

microsyringe connected by polyethylene tubing (PE 10) to a 30
gauge stainless steel infusion needle which fits within and
extends to the lower lip of the chronic third ventricular
cannula. The tubing and needle were filled with freshly made
solution to be injected just prior to the injection.

b. Jugular cannulae:
Silastic cannulae were placed in the right atrium via the
external jugular vein under tribromoethanol (TBE) anesthesia
(1 ml of 2.5% solution/100 gm BW), secured to the pectoral
muscle, threaded subcutaneously and externalized at the base
of the neck on the rat’s back

(108) .

The cannulae were

connected to extensions running outside the cages 2-3 h before
further experimentation.

3) Estradiol, progesterone and LH radioimmunoassays:
Plasma

samples

were

assayed

for

estradiol

and

progesterone levels using a double antibody radioimmunoassay
(RIA,

Diagnostic

Assay

Services,

Gaithersburg,
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sensitivities of the RlAs for estradiol and progesterone were
1.0 ng/liter and 1.0 ng/ml,

respectively,

with intraassay

coefficient of variation of 8 and 11%, respectively.
Serum

LH

levels

radioimmunoassay.

The

were

measured

sensitivity

of

by
this

double
assay

antibody
was

0.5

ng/tube, with an intraassay coefficient of variation of 7-8%.
All samples from the same experiment were assayed in the
same RIA.
4) Statistical analysis:
Data were analyzed by one-way analysis of variance with
the student-Newman Keuls post-hoc test or the Student's ttest. The 0.05 level of probability was used as the minimum
level of significance for differences between the means for
all experiments.

5) Drugs and chemicals:
All the drugs to be employed in the proposed experiments
were available from commercial sources. Purified preparations
of angiotensin II and oxytocin were available from Peninsula
Laboratories (San Carlos, CA). HPLC-purified 125-1 rat LH was
obtained from Hazleton Laboratories (Vienna, Virginia). Other
chemicals and reagents including progesterone were purchased
from Sigma Chemical Company (ST. Louis, MO). The pellets for
17-beta estradiol, progesterone and their placebo carrierbinder were purchased from Innovative Research of America
(Toledo,

OH) . Chemicals

for

intravenous

injections
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diluted in saline.

6) Experimental procedure
Effect

of

gonadal

hormones

on

the

stimulatory

effect

of

oxytocin on LH secretion.

1)Long

term

exposure

to

high

doses

of

estradiol

and/or

progesterone:
Ovariectomized female rats were separated into 4 groups
(7-8 rats/group).

Pellets containing placebo carrier-hinder

(control

17-beta

estradiol

(1

mg,

group)

both

group),

progesterone

(35

P4

or

mg,

E2

group),

estradiol

and

progesterone (1 mg 17-beta estradiol and 35 mg progesterone,
E2/P4

group)

were placed

subcutaneously

4 days

prior

to

progesterone doses

in

further experimentation.

2)

Short

term exposure

of varying

ovariectomized rats with or without estradiol-priming:
Ovariectomized female rats were separated into 6 groups
(7-8 rats/group) . Rats received subcutaneous 17-beta estradiol
pellets (1 mg) 2 days prior to further experimentation. On the
day of the experiment, various doses of progesterone (15 mg,
5 mg, 2.5 mg, 1.5 mg, 0.5 mg or 0.0 mg/rat in vegetable oil
vehicle) were administered, subcutaneously [P4(2.5), P 4 (1.5),
P4(0.5),

control,

E-P4(15),

E-P4(5)

groups]
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ovariectomized rats primed with estradiol.

Four other groups

of ovariectomized rats (7-8 rats/group) received various doses
of progesterone
vegetable

[25 mg,

oil vehicle;

15 mg,
P4(25),

5 mg/rat
P4(15),

or

0 mg/rat

P4(5)

and

in

control

groups, respectively].
Rats were housed and maintained according to guidelines
published in "NIH Principles for Use of Animals, Guide for
Care and Use of Laboratory Animals". All surgical procedures
were classified as USDA type D procedures. The surgery for
jugular cannulae placement takes approximately 5-10 min and
the stereotaxic ICV cannulae placement surgery takes 20-30
min. Sterilized materials and prophylactic antibiotics
(intramuscular injection and local ointment) were administered
to prevent infections for all recoverable surgeries. Any rats
displaying signs of illness were euthanized so they did not
suffer, consistent with the recommendations of the panel on
Euthanasia of the American Veterinary Medical Association.
Approximately

145

female

rats

were

used

for

these

experiments. All precautions were taken to avoid any stress in
handling the rats, which could affect the release of LH.
Plasma samples were obtained via jugular cannulae (placed
2 days earlier) from the unanesthetized, freely moving rats at
10 min before (PRE) and at 5, 15, 30, and 60 min following
oxytocin (10 ng) icv injection. Blood obtained from samples
were

transferred

to

heparinized

tubes

and

separated

immediately at 4*C. Plasma samples were stored at -80®C until
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analyzed by RIA. lev experiments started at 1300 hr (4 hours
after progesterone injection).
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CHAPTER IV
RESULTS :
1.

Long

term exposure of high doses

of

estradiol and/or

progesterone on oxytocin induced LH release
The results indicate that basal LH was higher in control,
ovariectomized

rats

treated

with

subcutaneous

pellets

containing placebo carrier-binder than in groups treated with
subcutaneous pellets containing estradiol,
both hormones
(control

(Fig 1) . Furthermore,

group)

responded

to

progesterone or

ovariectomized animals

icv oxytocin with a modest

decrease in plasma LH at 30 and 60 min after icv injection
(Fig

2).

Estradiol

or

progesterone

treatments,

alone,

decreased basal LH levels compared to control ovariectomized
animals (Fig 2; Pre time point). ICV oxytocin caused a modest
increase in plasma LH at 5, 15, and 30 min in estradioltreated animals compared with the proestrous LH surge in the
intact,

cycling

female

rats

(Fig

2) .

ICV

oxytocin

administration to progesterone-treated animals caused little
change in plasma LH. In animals treated with both estradiol
and progesterone,

basal LH levels were significantly lower

than in any other treatment groups (Fig 1 and Fig 2; Pre time
point). The icv injection of oxytocin to chronic estradiol and
progesterone treated animals resulted in no change in plasma
LH (Fig 2; E2/P4 group).

24
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Figure

l.

Effect

of

chronic

replacement

therapy

with

subcutaneous pellets containing placebo carrier-binder (CNTRL
group)t 17 8-Estradiol (1 mg, E2 group) , progesterone (35 mg,
P4 group), or both E2 and P4 (E2/P4 group) 2-4 days prior to
further experimentation on basal plasma concentrations
luteinizing

hormone.

Column

height

represents

mean

of
and

vertical bars represent SEM as determined from N = 7-8 rats.
A,

significantly

different

from

all

other

mean

values

(P<0.01). *, significantly different from CNTRL mean value
(P<O.OX) .
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Figure 2. Effect of a central injection of oxytocin (10 ug/
5ul) on plasma LH concentrations in ovariectomized rats which
have received subcutaneous pellets containing placebo carrierbinder

( CNTRL group),

progesterone

(35 mg,

17 6-Estradiol

(1 mg,

E2

group),

P4 group) , or both E2 and P4

(E2/P4

group) 2-4 days prior to further experimentation. At 13 00 hr
of the experimental day animals received an icv injection of
oxytocin and plasma samples were collected 10 min prior to icv
injection

(Pre) , or

5,

15,

30

or

60

min

after

the

icv

injection for plasma LH determination. Values represent mean
plasma LH concentration as determined from N = 7-8 rats.
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2.

Short

term

ovariectomized

exposure

to various

progesterone

rats with or without

doses

in

estradiol priming on

oxytocin-induced LH release

The effect of short term exposure to various progesterone
doses

in

estradiol-primed,

ovariectomized

rats

on

the

oxytocin-induced stimulation of LH release were investigated.
Once again, the results indicate that basal LH is highest in
ovariectomized rats,

next highest in animals treated with

estradiol alone (Fig 3; Pre time values), and lowest (in a
dose-related manner)

in those treated with high doses of

progesterone, alone [25 mg, P4(25) group; 15 mg, P4(15) group
or 5 mg, P4(5)

group; Pre time values in Fig 4]. Oxytocin

injection did not alter plasma LH in animals treated with any
of the progesterone doses, alone (Fig 4) . Following estradiol
treatment, alone, a very small decrease was seen at 5 min and
a small increase in plasma LH was seen at 15 and 30 min after
oxytocin injection
ovariectomized rats

(Fig 4, E group).
treated

In estradiol-primed,

acutely with

15 mg

[E-P4(15)

group] or 5 mg [E-P4 (5) group] progesterone at 900 hr, icv
administration of oxytocin 4 hr later caused an increase in
plasma LH (Fig 5) . This increase was significantly higher than
that seen in animals treated with estradiol, alone (E group.
Fig 5) , in animals receiving the lower dose of progesterone
[E-P4(5) group. Fig 5] at 5 min-30 min. In animals receiving
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Figure 3. Effect of a central injection of oxytocin (10 ug/5
ul) on plasma LH concentrations in ovariectomized rats which
have received subcutaneous pellets containing placebo carrierbinder (CNTL group) or 17 6-Estradiol (1 mg, E group) 2 days
prior

to

further

experimental

day,

experimentation.
animals

received

At

13 00

an

icv

hr

of

injection

the
of

oxytocin and plasma samples were collected 10 min prior to icv
injection

(Pre),

or

5,

15,

30

or

60 min

after

the

icv

injection for plasma LH determination. Values represent mean
plasma LH concentration as determined from N = 7-8 rats.
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Figure 4 . Effect of a central injection of oxytocin (10 ug/5
ul) on plasma LH concentrations in ovariectomized rats which
have received subcutaneous pellets containing 17 6-Estradiol
(1 mg, E group) 2 days prior to further experimentation, or an
acute subcutaneous injection of progesterone at 25 mg/0.6 ml
oil

[P4(25) group],

15 mg/0.3 ml oil [P4(15) group],

or 5

mg/0.3 ml oil [P4 (5) group ] at 900 hr of the experimental day.
At 13 00 hr an icv injection of oxytocin was administered and
plasma samples were collected 10 min prior to icv injection
(Pre) , or 5, 15, 30 or 60 min after the icv injection for
plasma

LH determination.

Values represent mean plasma

concentration as determined from N = 7-8 rats.
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Figure 5. Comparison of the effect of a central injection of
oxytocin

(10

ug/5ul)

on

plasma

LH

concentrations

in

ovariectomized rats which have received subcutaneous pellets
containing 17 6-Estradiol

(1 mg)

experimentation either without

2 days prior to further

(E group)

or with an acute

subcutaneous injection of progesterone at 15 mg/0.3 ml oil [EP4(15) group) or 5 mg/0.3 ml oil [E-P4(5) group] at 900 hr of
the experimental day. At 1300 hr an icv injection of oxytocin
was administered and plasma samples were collected 10 min
prior to icv injection (Pre), or 5, 15, 30 or 60 min after the
icv injection for plasma LH determination. Values represent
mean plasma LH concentration as determined from N = 7-8 rats.
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the higher dose of progesterone [E-P4 (15) group. Fig 5] the LH
stimulation resulting from icv oxytocin administration was
smaller and of shorter duration than even in the estradiol,
alone,

treatment

group;

suggesting

that

higher

doses

of

progesterone may inhibit the oxytocin-induced release of LH.
To test this directly, ovariectomized, estradiol primed rats
were give acute injections of 2.5 mg [P4(2.5) group], 1.5 mg
[P4(1.5) group] or 0.5 mg [P4(0.5) group] progesterone or 0.3
ml oil vehicle at 9:00 hr and then given an icv injection of
oxytocin at 1300 hr in order to evaluate the effect of the
dose

of progesterone

plasma

LH

in

on the oxytocin-induced

estradiol-primed

maximum response

in plasma LH

rats.

increase

Oxytocin

elicited

in
a

in animals given an acute

injection of 2.5 mg progesterone, with a surge which increased
5 min after icv injection, peaked at greater than 60 ng/ml at
30 min and was

still

significantly elevated over control

animals at 60 min [P4(2.5) group. Fig 6]. Oxytocin induced a
much

smaller,

but

significant,

increase

in plasma

LH

in

ovariectomized, estradiol-primed animals treated acutely with
1.5 mg progesterone

[P4(1.5)

group.

Fig 6] with increased

plasma LH levels at 5-30 min after icv injection, peaking with
a value of about 25 ng/ml at 5 min after icv injection. The
effect of icv oxytocin in animals receiving the lowest dose of
progesterone

[0.5 mg, P4 (0.5) group.

Fig 6] showed a much

smaller stimulation with small increases in plasma LH being
observed at

5 min and

at

60 min

after

icv

injection
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oxytocin.
priming,

Interestingly, in the animals receiving estradiol
alone,

no significant effect of icv oxytocin on

plasma LH was observed.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

38

Figure 6; Comparison of the effect of a central injection of
oxytocin

(10

ug/5

ul)

on

plasma concentrations

in

ovariectomized rats which have received subcutaneous pellets
containing 17 6-estradiol
experimentation

and

(1 mg)

anacute

2 days prior to further

subcutaneous

injection

of

progesterone at 2.5 mg/0.3 ml oil [P4(2.5)group]; 1.5 mg/0.3
ml oil [P4(1.5) group] or 0.5 mg/0.3 ml oil [P4(0.5) group];
or received 0.3 ml oil vehicle (CNTRL group) at 900 hr of the
experimental day. At 1300 hr an icv injection of oxytocin was
administered and plasma samples were collected 10 min prior to
icv injection (Pre),

or 5, 15,

30 or 60 min after the icv

injection for plasma LH determination. Values represent mean
plasma LH concentration ±sem as determined from N=7-8 rats.
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CHAPTER V

DISCUSSION:

The data demonstrate that for the expression of the
stimulatory role of oxytocin on plasma LH to be seen, serum
levels,

concentration ratios and exposure time of gonadal

hormones are critical. This stimulatory action of oxytocin
disappears when estradiol is removed. Furthermore, although a
small dose of progesterone synergizes with estradiol to cause
a greater release of LH by oxytocin, the action is reduced as
the dose of acutely administered progesterone increases in the
ovariectomized, estrogen-primed rats (Fig 6).
The data
reports

(30,

from the present study agree with previous
32)

that

oxytocin

exerts

a

physiologically

relevant, stimulatory influence on the preovulatory release of
LH on the afternoon of proestrus in cycling female rats (when
the

concentration

progesterone

is

of
low,

plasma

estradiol

but

level

increasing).

is high

and

Pharmacological

manipulation of endogenous oxytocin with selective oxytocin
antagonists and passive immunoneutralization with specific
oxytocin

antisera

result

in

significant

deficiencies

in

stimulated LH release in animal models with similar estradiol
and progesterone concentrations (30, 32) . Recently, Samson et
40
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al

(119)

developed

a novel

method

to

selectively

lesion

central oxytocin neurons with a ricin-cytotoxin conjugate to
reveal a physiologically relevant role for oxytocin within the
hypothalamus to control LHRH release on the afternoon of
proestrus in the steroid-primed LH surge model
results provide a possible
laboratories

describing

(119). Our

explanation for data from several
both

inhibitory

and

stimulatory

effects of oxytocin on LH. Changes in the concentration of
plasma gonadal hormones are critical to the action and effect
of central oxytocin on LH secretion. Two studies demonstrating
inhibitory effects of oxytocin on LH release were carried out
in

animal

hormones

models
(34,

associated

with

low

levels

43) . On the other hand,

of

ovarian

another group has

provided evidence for a direct, stimulatory action of oxytocin
on LH release from rat anterior pituitary cells in static
culture (31, 35), which is steroid-dependent (106). We have
shown

pretreatment with either an oxytocin antagonist or an

LHRH antagonist blocked the increase in plasma LH resulting
from a central injection of oxytocin on proestrus (when plasma
concentrations of gonadal steroids are high)

(12 0). These

results demonstrate that the oxytocin-induced
plasma

LH

apparently

is an

oxytocin

mediated

Additionally,

using

by

receptor-mediated

influencing

oxytocin-ricin

the
A

increase

in

event and

is

release

chain

of

LHRH.

conjugates

to

selectively target and destroy cells in vivo and in vitro that
possess oxytocin receptors, Samson and co-workers failed to
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demonstrate

that

oxytocin

acts

directly

on

the

anterior

pituitary, and provided evidence that oxytocin acts through
LHRH neurons centrally to affect LH release.
Evidence supporting the influence of plasma estradiol and
progesterone on distribution, content, synthesis, and release
of oxytocin in the CNS has been provided.

Treatment with

estradiol has been shown not only to enhance the oxytocin-like
immunoreactivity contained in discrete regions of the rat
brain (20), but also allows additional immunoreactive oxytocin
perikarya

and

demonstrate
estradiol

processes

no

to

be

oxytocin-like

treatment

(50,

51,

observed

in

areas

immunoreactivity
58) . The

which

prior

to

concentrations

of

oxytocin found in CNS nuclei fluctuate within the estrous
cycle (57). Oxytocin levels in the portal blood increase on
the afternoon of proestrus, correlating with the onset of the
preovulatory LH surge

(47). Studies examining the possible

influence of estrogen on oxytocin messenger RNA levels using
Northern blot and dot blot analysis provide evidence for a
role at the molecular level

(64-66). The possibility of a

direct effect of estrogen on transcription is indicated by the
presence

of

partial

estrogen-responsive-elements

located

upstream to the oxytocin transcription start site (67-69),
However, autoradiographic studies of estrogen binding have not
revealed

significant

numbers

of

supraoptic

neurons

with

nuclear estrogen receptors (70) . This is unlikely to represent
the only route of gonadal hormone action on the oxytocin
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system.

Other

hormone

responsiveness

putative

possibilities
by

include

the

increasing

modification

of

sensitivity

of

the

second messenger systems or membrane potential to

oxytocin. For LHRH gene expression, a long estrogen treatment
can induce increased roRNA levels and the stimulatory effects
of

estrogen

can

be

consequent

to

the

release

of

the

neuroendocrine peptide (71-73) . All these results suggest that
the increasing activity of oxytocin neurons during proestrus
(when

plasma

estradiol

levels

physiologically responsible for
results

are

high)

is

probably

inducing the LH surge. The

from the present study support the fact that the

stimulatory effect of centrally administered oxytocin can be
seen in a pharmacological model of the proestrous female rat,
and

that

the presence

of

physiologically

high

levels

of

estradiol are critical for the stimulatory effect of oxytocin
to be seen.
Our results demonstrate that progesterone also plays an
important role in this mechanism. In our study, both estradiol
and

progesterone

chronically

exerted

additive

negative

feedback effects on basal LH levels. ICV oxytocin inhibited LH
levels

in ovariectomized

rats,

and modestly

stimulate LH

levels (in most cases) in estradiol treated rats compared with
the proestrous LH surge in cycling female rats, but not in
rats treated with the highest dose of progesterone.

This

suppressive action of progesterone is reduced and even begins
to

synergize

with

estradiol

when

the

acute
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administered progesterone is reduced to 0.5-5 mg/rat (Fig 5,
Fig

6) . This

result

is

consistent

with

the

fact

that

progesterone administered early on the morning of proestrus
advanced

LH

release

by

several

hours

and

enhanced

the

magnitude of the estrogen-induced LH surge (96). The effect of
progesterone appears not to be mediated through the ovary
since studies in the rat have shown progesterone to stimulate
LH release in ovariectomized rats primed with estradiol (98100) . However, our studies show that the stimulatory effect of
progesterone required the presence of estradiol. These facts
are consistent with the negative

feedback of the gonadal

hormones on the basal release of LH. The results also relate
to the general mechanisms by which gonadal hormones exert
their effects on

different locations in the CNS to control LH

secretion; including effects on neurotransmitter synthesis and
release

dynamics,

requirement

of

to

receptor

estradiol

number

priming

and
for

affinity.

The

progesterone *s

stimulatory effect to be exhibited is obvious and may be due
to a critical dependence of progesterone on estradiol for the
induction of

its receptors

(103-104).

on the other hand,

progesterone's action might be due to neurotransmitter release
mechanisms while that of estradiol might be on synthesis of
neurotransmitters. This possibility is supported by the fact
that

progesterone

receptors

are

not

found

directly

on

hypothalamic LHRH neurons (107). Therefore, central oxytocin
may represent one of the mediating factors in the action of
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gonadal steroids on LHRH neurons. The effects of estrogen on
hypothalamic LHRH release might be mediated, in part, through
effects on oxytocin neurons surrounding LHRH neurons in the
hypothalamus

and

median

progesterone

receptors

eminence.
have

been

Indeed,

estradiol

identified

on

and

central

oxytocin neurons (121). Estrogen also exerts important effects
which sensitize the anterior pituitary to LHRH stimulation.
Drouva et al (122) provided evidence that estradiol increases
anterior pituitary protein kinase C activity both in vivo as
well as in vitro. Direct effects of estradiol on the pituitary
have been demonstrated in ovariectomized female rats in which
the vascular connections between the hypothalamus and the
pituitary

were

interrupted

surgically,

and

regrowth

was

prevented by insertion of a piece of aluminum foil; as well as
in experiments using dispersed pituitary cells in culture
(123-124).

On the other hand,

at the very least,

gonadal

hormones modulate the oxytocin receptors and interactions
involved in the stimulation of LH release in terms of its
qualitative nature, quantity, affinity and distribution. The
central

influence of gonadal steroids was also proven

in

experiments showing pretreatment with an oxytocin antagonist,
central administration of an oxytocin antisera or an LHRH
antagonist blocked the increase in plasma LH resulting from a
central injection of oxytocin. Several other neuropeptides and
monoaminergic neurotransmitters have been implicated in the
neuroendocrine regulation of LH secretion.

They primarily
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appear to work by altering the net release of LHRH from the
median

eminence

into

the

hypophyseal

portal

blood.

Surprisingly, most of the LHRH secretagogues or inhibitors
more or less appear to be dependent on the levels of plasma
gonadal hormones, especially physiologically high levels of
plasma estradiol. These
II,

glutamate,

However,

GABA,

include NE, epinephrine, angiotensin
CRF,

NPY,

and

the

opiates

(5-16).

direct evidence for these interactions and their

significance in the neuroendocrine regulation of LHRH and LH
secretion,

as well as the modulatory influence of plasma

estradiol/progesterone levels on those possible interactions
is controversial and largely unknown. Further work is needed
to clarify these issues.
Besides
stimulation

the modulation by
of

LH

release,

estradiol

the

acute

of the oxytocin

administration

of

progesterone also acted synergistically to enhance LH release
in

estradiol-primed,

manner
exert

ovariectomized

rats

in

dose-related

(Fig 5; Fig 6). How progesterone acts centrally to
this

regulatory

action
role

on
of

LH

release

remains

progesterone

on

unresolved.

the

The

neuroendocrine

regulation of LH secretion depends on the time and dose of its
administration
estradiol.

in

Long

relationship
term

to

the

administration

of

plasma

level

of

high

doses

of

progesterone failed to show the synergistic effect when serum
estradiol levels were similar to those attained in the most
recent experiments demonstrating synergism (Fig 2, Fig 5, Fig
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6). Such synergism was evident when progesterone levels were
probably closer to the expected physiological progesterone
level

seen

during

proestrus.

administered acutely

(s.c.)

When

progesterone

to estradiol-primed rats,

was
the

resulting stimulation of LH release in response to centrally
administered oxytocin demonstrated a bell-shaped dose response
(Fig 5, Fig 6). The results indicate that the lower doses of
progesterone synergistically enhance the

ability of oxytocin

to stimulate LH release in animals having physiologically high
levels of serum estradiol. The enhancement was maximum after
administration of 2.5 mg progesterone, but was also seen to a
lesser

degree

in

animals

treated

with

1.5

and

0.5

mg

progesterone. As the dose of progesterone increased further,
the synergism decreased. At the optimum progesterone dose ,
the level of LH stimulation was similar to that observed in
intact proestrous rats during the spontaneous LH surge, and is
higher than that observed in intact rats early on proestrus 30
min after oxytocin

injection.

likely due to differences

These differences

in the progesterone

are most

levels and

duration in the current experiments compared to intact cycling
rats.

In particular,

lower

doses

of

progesterone may

be

important to stimulate the start of the oxytocin-induced LH
release

in

estradiol-primed

ovariectomized

rats,

whereas

larger doses may help bring the LH surge back down to normal.
Interestingly, the lowest dose of progesterone in our study
(0.5 mg) stimulated oxytocin-induced LH release in a modest
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biphasic manner

(Fig 6). These data suggest low doses of

progesterone might start the oxytocin-induced LH release in
estradiol-primed

ovariectomized

rats,

and

that

this

stimulation of LH secretion could be brought back to normal as
progesterone levels continue to rise.
The

cellular

mechanisms

involved

in

the

acute

progesterone enhancement of oxytocin's stimulatory effect on
LH

release

in

estradiol

primed,

ovariectomized

rats

is

unclear. No effect of progesterone on LHRH receptor number in
the

pituitary has

been

reported,

suggesting

the

site

of

progesterone action must be at a level higher than the LHRH
receptor (110). Other reports show that progesterone enhances
the pituitary LH response to other secretagogues which act
prior to the LHRH receptor (111) . The results from our present
study suggest that the action of progesterone may be required
for

a

functional

interaction

between

oxytocin,

other

neuropeptides and their receptors. Alternatively, progesterone
may activate additional mechanisms which

estradiol does not

affect, which are then required for the facilitation of LH
secretion by oxytocin.
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CHAPTER VI
SUMMARY
In

summary,

both

estradiol

and

progesterone

exert

negative feedback effects on basal LH secretion, and their
combined effect was additive. Centrally administered oxytocin
inhibited the high plasma LH levels seen in ovariectomized
rats. In contrast, in most cases, oxytocin caused LH levels to
increase

in

estradiol-treated

rats

following

its

icv

injection, although the magnitude of that increase is very
small compared to the proestrous surge or the estradiol-primed
rat

given

2.5

progesterone,

mg

progesterone.

alone,

there was

In

animals

treated

with

little effect of centrally

administered oxytocin on plasma LH. Oxytocin did not alter
plasma LH concentrations in animals treated with long term
progesterone and/or estradiol. The results support the fact
that the stimulatory effect of centrally administered oxytocin
can be seen in a pharmacological model of the proestrous
female rat,

and that the presence of physiologically high

levels of estradiol are critical for the stimulatory effect of
oxytocin

to

progesterone,

be

seen.

oxytocin

In

the

exerts

absence
an

of

inhibitory

estradiol

or

influence

on

plasma LH. The level of stimulation by oxytocin on plasma LH
was critically dependent on the optimal dose of progesterone.
Progesterone's influence on the oxytocin-induced change in LH
release was

both

dose

and

time

dependent.

Low
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progesterone
inhibit»

synergistically

enhance»

while

high

doses

the ability of oxytocin administered centrally to

stimulate LH secretion. The fact that the optimal dose of
progesterone can influence oxytocin-induced LH release in a
manner similar to that seen in cycling female rats on the
afternoon of proestrus» and even stimulate LH release at 30
min after icv oxytocin suggests that the duration and/or dose
of estradiol and progesterone exposure are critical for the
expression of the stimulatory oxytocin effect. On the other
hand» the progesterone levels seen in intact female rats on
proestrus are dynamic » and are probably lower than that seen
in most of the acutely progesterone-treated » ovariectomized
groups. The dynamic changes occuring in plasma estradiol and
progesterone in relation to each other throughout proestrus
are probably critically important to the expression of the
oxytocin stimulation of LH secretion. Alternatively,
possible

that

elements/inputs

if

other

were

also

critically
stimulated

it is

important
in

the

key

present

experiments» or if the oxytocin challenge could be given at
the time of the endogenous surge » the resulting surge of LH
might resemble even more closely that seen on the afternoon of
proestrus prior to ovulation in intact» cycling rats. When
ovariectomized rats are estradiol-primed» and the
progesterone level is carefully controlled» oxytocin given
centrally induces an increase in plasma LH which resembles
the endogenous LH surge seen on the afternoon of proestrus
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in the cycling, intact female rat. The pharmacological model
of the proestrous surge can be used to evaluate the
influence of oxytocin on LH secretion, as well as the
important interaction, occurring between oxytocin and other
central neurotransmitters to provide that regulation.
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